LDS/Medical Tests/Fine Needle Aspiration Biopsy and Fine Needle Core Biopsy

Fine Needle Aspiration Biopsy and Fine Needle Core Biopsy

Fine needle aspiration is a minimally invasive procedure used to obtain diagnostic samples in clinical medicine. It has become increasingly popular in the recent years due to its excellent patient acceptability. When used in an appropriate clinical scenario, it is highly cost-effective; simple, reliable in procuring adequate diagnostic material, minimal complications, and quicker recovery time for the patients.

The procedure is fairly simple when used to procure samples from a superficial tissue such as a thyroid nodule, breast mass, enlarged lymph nodes, and head and neck lesions. Lesions involving the internal tissues/organs require the use of imaging studies such as endoscopic ultrasonography (EUS), endobronchial ultrasound (EBUS) or Computerized Tomography (CT) guidance for sampling of lesions in the lung. GI tract, liver, pancreas, adrenal, etc.

Tissue samples can be obtained using fine needle aspiration (FNA) for cytology and/or fine needle biopsy (FNB) and the decision is made by the endoscopist depending on the clinical indication/need. Generally, a local anesthesia suffices for percutaneous fine needle aspiration of a palpable lesions. If imaging is required, the patient is prepared accordingly. Once a target lesion is identified, a 22- or 25-gauge needle is introduced into the lesion and using a 10 (or 20) ml syringe, a negative pressure is applied. The needle is gently moved in and out of the lesion in a to-and-fro motion to aspirate the lesion. Upon removal of the needle, the material is expelled onto a set of glass slides. If the aspiration yields a generous sample, the remaining material can be preserved in a fixative provided by the cytology laboratory to facilitate immunohistochemistry and other ancillary studies. Fine needle core biopsies require a slightly wider needle (19-gauge) and longer application of negative pressure (approximately 60 seconds) before one or two to-and-fro motions.

The procedure is generally safe and easy to perform. It is relatively contraindicated in hemodynamically unstable patients and patients with poor performance status. The procedure is well-tolerated by the patients. Complications are rare and their incidence can be further reduced by proper patient selection, evaluation and appropriate preparation. which include infection, hemorrhage, perforation, fistula formation and needle-tracking of the malignant cells or infectious agents.

  • Diagnosis and management of various malignancies such as carcinoma, metastatic melanoma and lymphoma
  • Diagnosis and management of localized infectious processes such as tuberculosis, bacterial, parasitic or fungal infection
  • Diagnosis of sarcoidosis, thyroid nodules, adrenal nodules, pancreatic masses, liver lesions, etc.
  • Staging of known malignancies such as non-small cell lung cancer
  • Rarely, FNA is therapeutic in draining cyst contents or abscesses
Interpretation of the cytology specimens and cultures from various sites is dependent on the clinical presentation and pathologic findings.

There are no universal reference ranges

Cytology specimens are processed in the lab based on the commercial platforms according to the manufacturer’s guidelines. Cytospin smears are stained with Pap stain, Diff-Quik/ Romanowsky and H&E stains. If there is enough specimen, a cell block is prepared which allows immunohistochemistry. Biopsies are stained with hematoxylin and eosin, and various special and immunohistochemical stains at the discretion of the pathologist. If the sampling is adequate and a hematolymphoid neoplasm other than Hodgkin lymphoma is clinically suspected, a fresh piece of tissue may be utilized for flow cytometric analysis.

Fine needle aspiration samples are used to make two to four direct smears. Generally, one or two of these slides are used at the site of the procedure by a cytotechnologist or a pathologist to check adequacy of the sample. Remaining material, if any, should to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory.

Fine needle biopsy specimens are placed either in sterile saline or in a formalin fixative. Specimens requiring flow cytometry should be sent fresh to the laboratory in a sterile container or RPMI medium. If culture is indicated, core biopsy tissue for culture should be sent in a sterile container (or appropriate transport media) to the laboratory for microbiological assessment. In the case of fine needle aspiration samples, the entire samples may be submitted in the aspiration syringe (needle removed).

Varies from case to case.
Usually 24 hours for routine light microscopy, longer for immunohistochemical stains, flow cytometry and other ancillary studies which vary from case to case. Adequacy checks, if performed at the site of the procedure, are usually reported in less than twenty minutes.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login